HPLC analysis of amifostine

Pharmacy and Pharmacology Communications

Volumn 5, Issue 9, 1999, Pages 541-543

  Mandal, T K ^a   Womack, I ^a  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; AMIFOSTINE; CHLOROACETIC ACID; RADIOPROTECTIVE AGENT; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; WR 149846;

ACCURACY; ARTICLE; ELECTROCHEMICAL DETECTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH; STANDARD; TIME;

EID: 0032844216     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: 10.1211/146080899128735315     Document Type: Article

References (12)

1. Anderson, K. W., Krohn, K. A., Grunbaum, Z., Phillips, R. B., Mahler, P. A., Menard, T. W., Spence, A. M., Rasey, J. S. (1984) Analysis of S-35 labeled WR-2721 and its metabolites in biological fluids. Int. J. Radiat. Oncol. Biol. Phys. 10: 1511-1515
2. Fatome, M., Courteille, F., Laval, J. D., Roman, V. (1987) Radioprotective activity of ethylcellulose microspheres containing WR 2721, after oral administration. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 52: 21-29
3. Korst, A. E., Gall, H. E., Vermorken, J. B., van der Vijgh, W. J. (1996) Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient. Cancer Chemother. Pharmacol. 39: 162-166
4. Korst, A. E., Vermorken, J. B., van der Vijgh, W. J. (1997) High-performance liquid chromatographic assay using electrochemical detection for the combined measurement of amifostine, WR 1065 and the disulfides in plasma. J. Chromatogr. B. Biomed. Sci. Appl. 23: 167-174
5. Lamperti, A., Ziskin, M. C., Bergey, E., Gorlowski, J., Sodicoff, M. (1990) Transdermal absorption of radioprotectors in the rat using permeation-enhancing vehicles. Radiat. Res. 124: 194-200
6. Sodicoff, M., Lamperti, A., Ziskin, M. C. (1990) Transdermal absorption of radioprotectors using permeation-enhancing vehicles. Radiat. Res. 121: 212-219
7. Souid, A. K., Newton, G. L., Dubowy, R. L., Fahey, R. C., Bernstein, M. L. (1998) Determination of the cytoprotective agent WR-2721 (amifostine, ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography. Cancer. Chemother. Pharmacol. 42: 400-406
8. Spencer, C. M., Goa, K. L. (1995) Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector. Drugs 50: 1001-1031
9. Swynnerton, N. F., McGovern, E. P., Nino, J. A., Mangold, D. J. (1984) An improved HPLC assay for S-2-(3-aminopropylamino)ethyl phosphorothioate (WR-2721) in plasma. Int. J. Radiat. Oncol. Biol. Phys. 10: 1521-1524
10. Swynnerton, N. F., Huelle, B. K., Mangold, D. J., Ludden, T. M. (1986) A method for the combined measurement of ethiofos and WR-1065 in plasma: application to pharmacokinetic experiments with ethiofos and its metabolites. Int. J. Radiat. Oncol. Biol. Phys. 12: 1495-1499
11. Thompson, D. C., Wyrick, S. D., Holbrook, D. J., Chaney, S. G. (1995) Effect of chemoprotective agent WR-2721 on disposition and biotransformations of ormaplatin in the Fischer 344 rat bearing a fibrosarcoma. Cancer Res. 55: 2837-2846
12. Wasserman, T. (1999) Radioprotective effects of amifostine. Semin. Oncol. 26 (Suppl. 7): 89-94